Logo image of ETU.CA

E2GOLD INC (ETU.CA) Stock Fundamental Analysis

TSX-V:ETU - TSX Venture Exchange - CA26932P1027 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

0

ETU gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ETU may be in some trouble as it scores bad on both profitability and health. ETU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ETU had negative earnings in the past year.
In the past 5 years ETU always reported negative net income.
In the past 5 years ETU always reported negative operating cash flow.
ETU.CA Yearly Net Income VS EBIT VS OCF VS FCFETU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

Industry RankSector Rank
ROA -670.32%
ROE N/A
ROIC N/A
ROA(3y)-641.41%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETU.CA Yearly ROA, ROE, ROICETU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ETU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETU.CA Yearly Profit, Operating, Gross MarginsETU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ETU has been increased compared to 1 year ago.
The number of shares outstanding for ETU has been increased compared to 5 years ago.
ETU has a worse debt/assets ratio than last year.
ETU.CA Yearly Shares OutstandingETU.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2022 2023 2024 50M 100M 150M 200M
ETU.CA Yearly Total Debt VS Total AssetsETU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

ETU has an Altman-Z score of -96.32. This is a bad value and indicates that ETU is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -96.32
ROIC/WACCN/A
WACCN/A
ETU.CA Yearly LT Debt VS Equity VS FCFETU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2022 2023 2024 0 -2M -4M -6M

2.3 Liquidity

ETU has a Current Ratio of 0.17. This is a bad value and indicates that ETU is not financially healthy enough and could expect problems in meeting its short term obligations.
ETU has a Quick Ratio of 0.17. This is a bad value and indicates that ETU is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
ETU.CA Yearly Current Assets VS Current LiabilitesETU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.76% over the past year.
EPS 1Y (TTM)64.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETU.CA Yearly Revenue VS EstimatesETU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2022 2023 2024
ETU.CA Yearly EPS VS EstimatesETU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ETU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ETU.CA Price Earnings VS Forward Price EarningsETU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ETU.CA Per share dataETU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ETU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

E2GOLD INC

TSX-V:ETU (3/7/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)01-24 2022-01-24
Inst Owners12.98%
Inst Owner ChangeN/A
Ins Owners8.53%
Ins Owner ChangeN/A
Market Cap1.15M
Analysts86.67
Price Target0.1 (1900%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -670.32%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-641.41%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -96.32
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)44.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y69.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.89%
OCF growth 3YN/A
OCF growth 5YN/A